Cubist Systematic Strategies »

Candel Therapeutics shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2024-06-30 $162k 26k 6.20

More positions owned by Cubist Systematic Strategies

NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Apple (AAPL)
Arm Holdings Sponsored Ads (ARM)
Broadcom (AVGO)
General Motors Company (GM)
Super Micro Computer Call Option (SMCI)
Amazon (AMZN)
Spotify Technology S A SHS (SPOT)
Tesla Motors Call Option (TSLA)
Dell Technologies CL C (DELL)
Microstrategy Cl A New Call Option (MSTR)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)

View all positions for Cubist Systematic Strategies

Top funds holding Candel Therapeutics

Northpond Ventures
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Nuveen Asset Management
Bridgeway Capital Management
Citadel Advisors
Mml Investors Services
Susquehanna International
HB Wealth Management
Bank of New York Mellon
Bank of America Corporation
Charles Schwab Investment Management
Cubist Systematic Strategies

View all funds holding Candel Therapeutics